Last Posted: Feb 14, 2020
- Evaluation of current genetic testing reports in German-speaking countries with regard to secondary use and future electronic implementation
EJHG, February 13, 2020 - [Perspectives of the use of pharmacogenetic tests in neurology and psychiatry].
Kostyuk G P et al. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2019 119(9) 131-135 - Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.
Sánchez-Durán María Ángeles et al. BMC pregnancy and childbirth 2019 Aug 19(1) 274 - Focus group testing of a mobile app for pharmacogenetic-guided dosing.
Dodson Crystal Heath et al. Journal of the American Association of Nurse Practitioners 2020 Feb - Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts.
Brough Joe et al. American journal of medical genetics. Part C, Seminars in medical genetics 2020 Feb - Primary care physician experiences utilizing a family health history tool with electronic health record-integrated clinical decision support: an implementation process assessment.
Lemke Amy A et al. Journal of community genetics 2020 Feb - Biomarkers in Lung Cancer.
Sears Catherine R et al. Clinics in chest medicine 2020 Mar 41(1) 115-127 - BRCA1 & BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.
Apostolou Paraskevi et al. International journal of cancer 2020 Feb - Circulating tumor DNA analysis in the era of precision oncology.
Said Rabih et al. Oncotarget 2020 Jan 11(2) 188-211 - Enhancing Genetic Medicine: Rapid and Cost-Effective Molecular Diagnosis for a GJB2 Founder Mutation for Hearing Impairment in Ghana.
Adadey Samuel M et al. Genes 2020 Jan 11(2)
.jpeg)
No hay comentarios:
Publicar un comentario